ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Ophthalmology

Top Ophthalmology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALAN ZALTA MD

Ophthalmology

7,068

$459K

711
629 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

56%
prescriptions for brand name drugs

Avg: 58%

$65
Average prescription price

Avg: $75

JOHN AEY M.D.

Ophthalmology

6,961

$473K

1088
996 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 58%

$68
Average prescription price

Avg: $75

JAMES MCHALE M.D.

Ophthalmology

5,877

$479K

1519
1079 are 65+

16%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 58%

$81
Average prescription price

Avg: $75

KARL PAPPA M.D.

Ophthalmology

5,854

$449K

876
813 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 58%

$77
Average prescription price

Avg: $75

KATHLEEN LAMPING MD

Ophthalmology

5,474

$361K

883
837 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 58%

$66
Average prescription price

Avg: $75

JOHN PAJKA MD

Ophthalmology

5,287

$327K

1482
1396 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

73%
prescriptions for brand name drugs

Avg: 58%

$62
Average prescription price

Avg: $75

HOWARD BELL MD

Ophthalmology

5,207

$403K

966
899 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 58%

$77
Average prescription price

Avg: $75

JOHN BURCHFIELD M.D.

Ophthalmology

5,164

$284K

738
665 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $75

MATTHEW WILLETT M.D.

Ophthalmology

5,103

$403K

766
708 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 58%

$79
Average prescription price

Avg: $75

JEFFREY ZINK MD

Ophthalmology

5,033

$395K

571
509 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 58%

$78
Average prescription price

Avg: $75

JONATHAN EISENGART M.D.

Ophthalmology

4,896

$289K

660
567 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 58%

$59
Average prescription price

Avg: $75

TAC LEE MD

Ophthalmology

4,857

$498K

1215
1112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

82%
prescriptions for brand name drugs

Avg: 58%

$103
Average prescription price

Avg: $75

THOMAS CHI MD

Ophthalmology

4,730

$449K

1034
979 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 58%

$95
Average prescription price

Avg: $75

EDWARD ROCKWOOD MD

Ophthalmology

4,629

$240K

711
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 58%

$52
Average prescription price

Avg: $75

HAI-SHIUH WANG M.D.

Ophthalmology

4,584

$281K

899
815 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 58%

$61
Average prescription price

Avg: $75

MICHAEL GRESSEL M.D.

Ophthalmology

4,562

$327K

789
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 58%

$72
Average prescription price

Avg: $75

JOHN KUNESH M.D.

Ophthalmology

4,484

$246K

941
895 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 58%

$55
Average prescription price

Avg: $75

STEPHEN ORR MD

Ophthalmology

4,202

$329K

843
775 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

74%
prescriptions for brand name drugs

Avg: 58%

$78
Average prescription price

Avg: $75

KEITH WILSON M.D.

Ophthalmology

4,171

$189K

1020
931 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 58%

$45
Average prescription price

Avg: $75

CARL MINNING MD

Ophthalmology

4,075

$204K

820
778 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 58%

$50
Average prescription price

Avg: $75

MICHAEL KUNESH M.D.

Ophthalmology

4,067

$241K

762
709 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 58%

$59
Average prescription price

Avg: $75

LARRY FISH M.D., PH.D.

Ophthalmology

3,826

$348K

863
774 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 58%

$91
Average prescription price

Avg: $75

DOUGLAS RHEE M.D.

Ophthalmology

3,794

$322K

443
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 58%

$85
Average prescription price

Avg: $75

AMY KOPP MD

Ophthalmology

3,740

$413K

706
656 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 58%

$110
Average prescription price

Avg: $75

RICHARD LEHRER M.D.

Ophthalmology

3,673

$323K

723
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 58%

$88
Average prescription price

Avg: $75

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank